GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ibnsina Pharma (CAI:ISPH) » Definitions » PB Ratio

Ibnsina Pharma (CAI:ISPH) PB Ratio : 4.51 (As of Apr. 17, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Ibnsina Pharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-17), Ibnsina Pharma's share price is E£9.08. Ibnsina Pharma's Book Value per Share for the quarter that ended in Dec. 2024 was E£2.02. Hence, Ibnsina Pharma's PB Ratio of today is 4.51.

Warning Sign:

Ibnsina Pharma stock PB Ratio (=4.68) is close to 3-year high of 4.68.

The historical rank and industry rank for Ibnsina Pharma's PB Ratio or its related term are showing as below:

CAI:ISPH' s PB Ratio Range Over the Past 10 Years
Min: 0.93   Med: 3.5   Max: 19.33
Current: 4.51

During the past 9 years, Ibnsina Pharma's highest PB Ratio was 19.33. The lowest was 0.93. And the median was 3.50.

CAI:ISPH's PB Ratio is ranked worse than
93.27% of 104 companies
in the Medical Distribution industry
Industry Median: 1.19 vs CAI:ISPH: 4.51

During the past 12 months, Ibnsina Pharma's average Book Value Per Share Growth Rate was 40.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 15.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 10.60% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Ibnsina Pharma was 54.00% per year. The lowest was 4.60% per year. And the median was 15.35% per year.

Back to Basics: PB Ratio


Ibnsina Pharma PB Ratio Historical Data

The historical data trend for Ibnsina Pharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibnsina Pharma PB Ratio Chart

Ibnsina Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PB Ratio
Get a 7-Day Free Trial Premium Member Only 3.58 2.69 1.73 2.18 3.47

Ibnsina Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.18 1.56 1.76 2.82 3.47

Competitive Comparison of Ibnsina Pharma's PB Ratio

For the Medical Distribution subindustry, Ibnsina Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ibnsina Pharma's PB Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ibnsina Pharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Ibnsina Pharma's PB Ratio falls into.


;
;

Ibnsina Pharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Ibnsina Pharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=9.08/2.015
=4.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Ibnsina Pharma  (CAI:ISPH) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Ibnsina Pharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Ibnsina Pharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ibnsina Pharma Business Description

Traded in Other Exchanges
N/A
Address
Industrial zone 1, PO box 91, Obour, EGY
Ibnsina Pharma is an Egypt based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, and packaging, market research, and analysis.

Ibnsina Pharma Headlines

No Headlines